The dual-hit metabolic modulator LDCA synergistically potentiates doxorubicin to selectively combat cancer-associated hallmarks

Suchandrima Saha(Indian Institute of Chemical Biology), Samir Kumar Dutta(Indian Institute of Chemical Biology)

RSC Advances

January 1, 2017

10.1039/c7ra08625c

Cited by 2

Related Papers

A potent tumoricidal co-drug ‘Bet-CA’ - an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cells

|Scientific Reports|2015|38